{"id":31816,"date":"2022-11-18T10:10:20","date_gmt":"2022-11-18T05:10:20","guid":{"rendered":"https:\/\/pr.asianetpakistan.com\/?p=102648"},"modified":"2022-11-18T10:10:20","modified_gmt":"2022-11-18T05:10:20","slug":"tjp-labs-inc-amends-its-drug-establishment-license-and-achieves-approval-for-active-pharmaceutical-ingredients","status":"publish","type":"post","link":"https:\/\/myanmarnewsgazette.com\/tjp-labs-inc-amends-its-drug-establishment-license-and-achieves-approval-for-active-pharmaceutical-ingredients\/","title":{"rendered":"TJP Labs Inc. Amends Its Drug Establishment License and Achieves Approval for Active Pharmaceutical Ingredients"},"content":{"rendered":"
PICKERING, Ontario, Nov. 17, 2022 (GLOBE NEWSWIRE) — TJP Labs Inc. (“TJP Labs”) is North America’s leading full-service contract manufacturer of premier next-generation products, focusing on modern oral nicotine pouches and oral delivery solutions for caffeine and other nutraceutical products. Today, TJP Labs announced that after completing a thorough regulatory assessment and meeting all GMP requirements, it received a notice of compliance for Active Pharmaceutical Ingredients (API) following an audit by the Health Canada Drug GMP Inspection Program.<\/p>\n
The announcement aligns with TJP Labs’ strategy to offer drug manufacturing services, and the new achievement enables TJP Labs to spearhead further licensable activities.<\/p>\n
Speaking on the achievement, David Richmond-Peck, CEO of TJP Labs, remarked:<\/p>\n
“I cannot overstate the significance of this most recent compliant rating by Health Canada, and I congratulate our quality and manufacturing teams on their continued success.<\/p>\n
GMP certification for Active Pharmaceutical Ingredients accelerates TJP’s bold innovation strategy in the modern oral and beyond nicotine categories. Furthermore, it reinforces that our facilities operate to a set of internationally recognized pharmaceutical standards to ensure product quality and safety.<\/p>\n
The modern oral category is seeing exponential growth and this critical API milestone positions TJP as a formidable and aggressive partner. There is a growing demand for innovation, and our certifications give us the unique ability to provide more value-added products and services. But, most importantly, it allows us to offer a broad range of best-in-class products across multiple categories. It also enhances TJP’s long-term value for our investors.”<\/p>\n
About TJP Labs Inc.\u00a0<\/strong> Contacts<\/strong><\/p>\n David Richmond-Peck –\u00a0business@tjplabs.com<\/a><\/p>\n
\nTJP Labs is a leading North American full-service manufacturer of premium quality next-generation products, specializing in modern oral nicotine, energy, and nutraceutical pouches. Our products are manufactured and packaged in our DEL, Site-Licensed, cGMP\/HACCP compliant, ISO 9001:2015 certified state-of-the-art facilities.<\/p>\n